ITMI20031292A1 - Derivati biciclici nk-2 antagonisti selettivi. - Google Patents
Derivati biciclici nk-2 antagonisti selettivi.Info
- Publication number
- ITMI20031292A1 ITMI20031292A1 IT001292A ITMI20031292A ITMI20031292A1 IT MI20031292 A1 ITMI20031292 A1 IT MI20031292A1 IT 001292 A IT001292 A IT 001292A IT MI20031292 A ITMI20031292 A IT MI20031292A IT MI20031292 A1 ITMI20031292 A1 IT MI20031292A1
- Authority
- IT
- Italy
- Prior art keywords
- selective antagonists
- bicyclic derivatives
- bicyclic
- derivatives
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001292A ITMI20031292A1 (it) | 2003-06-25 | 2003-06-25 | Derivati biciclici nk-2 antagonisti selettivi. |
| PCT/EP2004/051210 WO2005000845A2 (en) | 2003-06-25 | 2004-06-23 | Bicyclic derivatives as nk-1 and nk-2 antagonists |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001292A ITMI20031292A1 (it) | 2003-06-25 | 2003-06-25 | Derivati biciclici nk-2 antagonisti selettivi. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ITMI20031292A0 ITMI20031292A0 (it) | 2003-06-25 |
| ITMI20031292A1 true ITMI20031292A1 (it) | 2004-12-26 |
Family
ID=30131291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT001292A ITMI20031292A1 (it) | 2003-06-25 | 2003-06-25 | Derivati biciclici nk-2 antagonisti selettivi. |
Country Status (2)
| Country | Link |
|---|---|
| IT (1) | ITMI20031292A1 (it) |
| WO (1) | WO2005000845A2 (it) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008106128A2 (en) | 2007-02-26 | 2008-09-04 | Vitae Pharmaceuticals, Inc. | CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1 |
| AR069207A1 (es) | 2007-11-07 | 2010-01-06 | Vitae Pharmaceuticals Inc | Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1 |
| EP2229368A1 (en) | 2007-12-11 | 2010-09-22 | Vitae Pharmaceuticals, Inc. | Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| TW200946520A (en) | 2008-05-01 | 2009-11-16 | Vitae Pharmaceuticals Inc | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| TW201016691A (en) | 2008-07-25 | 2010-05-01 | Boehringer Ingelheim Int | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| CA2730499A1 (en) | 2008-07-25 | 2010-01-28 | Boehringer Ingelheim International Gmbh | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| JP5679997B2 (ja) | 2009-02-04 | 2015-03-04 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状阻害剤 |
| UA109255C2 (ru) | 2009-04-30 | 2015-08-10 | Берінгер Інгельхайм Інтернешнл Гмбх | Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1 |
| WO2011011123A1 (en) | 2009-06-11 | 2011-01-27 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure |
| WO2011002910A1 (en) | 2009-07-01 | 2011-01-06 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| WO2011159760A1 (en) | 2010-06-16 | 2011-12-22 | Vitae Pharmaceuticals, Inc. | Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use |
| WO2011161128A1 (en) | 2010-06-25 | 2011-12-29 | Boehringer Ingelheim International Gmbh | Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders |
| MX2013004699A (es) | 2010-11-02 | 2013-05-22 | Boehringer Ingelheim Int | Combinaciones farmaceuticas para el tratamiento de trastornos metabolicos. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0028964D0 (en) * | 2000-11-28 | 2001-01-10 | Smithkline Beecham Spa | Novel compounds |
| ATE313539T1 (de) * | 2001-04-11 | 2006-01-15 | Glaxosmithkline Spa | Chinolin-4-carboxamidderivate als nk-3 und nk-2 rezeptor antagonisten |
-
2003
- 2003-06-25 IT IT001292A patent/ITMI20031292A1/it unknown
-
2004
- 2004-06-23 WO PCT/EP2004/051210 patent/WO2005000845A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005000845A2 (en) | 2005-01-06 |
| WO2005000845A3 (en) | 2005-04-07 |
| ITMI20031292A0 (it) | 2003-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20054015D0 (no) | Hurtige absorpsjons selektive 5-HT agonist formuleringer. | |
| MA29043B1 (fr) | Derives de benzimidazole aryloxy - substitues | |
| NO20053748D0 (no) | Pyrrolopyridazinderivater. | |
| IS7697A (is) | Pýrimídýlsúlfónamíðafleiður sem miðlar flakkboðaviðtaka | |
| DE602004021572D1 (de) | SUBSTITUIERTE 8-PERFLUORO-6,7,8,9-TETRAHYDROPYRIMIDOi1,2-A PYRIMIDIN-4-ON-DERIVATE | |
| NL1030324A1 (nl) | Sulfonylbenzimidazoolderivaten. | |
| DE602005021959D1 (de) | Substituierte diazaspiroä4.5üdecanderivate und der | |
| FI20030261A0 (fi) | Iskulaite | |
| ITMI20031292A1 (it) | Derivati biciclici nk-2 antagonisti selettivi. | |
| EP1643987A4 (en) | Podophyllotoxin DERIVATIVES | |
| PT1511718E (pt) | Derivados de n-acilaminobenzeno como inibidores selectivos de monoamina-oxidase b | |
| IS8278A (is) | Sýkóprópýl afleiður sem NK3 viðtaka mótlyf | |
| DE502004004326D1 (de) | Signalgerät | |
| BE1015485B5 (nl) | Boorinrichting. | |
| DE602004008447D1 (de) | 7-(ä1,4üdioxan-2-yl)-benzothiazol derivative als adenosin-rezeptoren liganden | |
| ITMI20020597A0 (it) | Derivati del probucolo | |
| ITMI20031290A0 (it) | Derivati chinolinici nk-2 antagonisti selettivi | |
| EP1598335A4 (en) | prostaglandin | |
| NL1026468A1 (nl) | Spoorwegconstructie. | |
| ES1055830Y (es) | Mosquitera. | |
| ITMO20030041A1 (it) | Mezzi decoratori tubolari. | |
| ES1053961Y (es) | Barandilla. | |
| NL1027301A1 (nl) | Tropaanderivaten. | |
| ES1056476Y (es) | Columpio. | |
| NL1022330A1 (nl) | Verkeersinformatieportaal. |